Trial intelligence / Profile preview

Sufentanil with Lidocaine for Anesthesia in Irreversible Pulpitis

NCT01572116Phase 2Completed

Sponsor
Islamic Azad University
Start
Jan 2010
Primary completion
Jun 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in irreversible pulpitis comparing Placebo Control with Sufentanil Group (2 arms). Primary endpoint: Depth of anesthesia. Started Jan 2010; status: completed.

02

Drugs

sufentanil
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT01572116.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01572116.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call